Increased CD38+ T cell subsets might aggravate ILD progression of MDA5+ DM through activating the type I IFN pathway, which provides a novel clue to the mechanism of lung exacerbation and therapeutic target for CD38 positive cells in patients of MDA5+ DM. Here, CD38 is linked to interstitial lung disease.